Clinical Scorecard: Enhancing Computed Tomography Image Quality with High-Flow Contrast Administration via High-Pressure Central Venous Catheter in Critically Ill Patients

At a Glance

Key Highlights

• Standard CVCs allow injection rates up to 5 mL/s but are not recommended for high-pressure injections; HP CVCs enable higher flow rates.
• In this study, HP CVCs allowed a median flow rate of 7.7 mL/s compared to 3.5 mL/s with standard CVCs without adverse events.
• No significant improvement in objective image quality (aortic and liver SNR and CNR) was observed with high-flow CM injection via HP CVC.

Guideline-Based Recommendations

Diagnosis

• Use CECT with contrast media injection for diagnostic imaging in critically ill patients requiring thoracic and/or abdominal evaluation.

Management

• Consider HP CVCs for high-flow contrast media injection to safely achieve higher injection rates up to approximately 7.7 mL/s.
• Maintain contrast media volume normalized to body weight consistent across injection methods.

Monitoring & Follow-up

• Monitor for adverse events related to high-pressure or high-flow contrast injection, although none were observed in this series.
• Assess image quality using signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) metrics at arterial and portal phases.

Risks

• Be aware of risks associated with high-pressure injections such as catheter displacement, ballooning, rupture, and contrast extravasation.
• Recognize that standard CVCs are not recommended for pressure injections above 5 mL/s.

Patient & Prescribing Data

Critically ill adult patients with superior vena cava central venous catheters undergoing thoracic and/or abdominal CECT

High-flow contrast injection via HP CVCs is feasible and safe but does not significantly improve objective image quality compared to standard flow rates.

Clinical Best Practices

• Use dedicated HP CVC lumens (e.g., 14-gauge medial lumen) for high-flow contrast injection to minimize risk.
• Maintain consistent contrast media volume per body weight and injection protocols aside from flow rate to ensure comparability.
• Adjust acquisition timing in CECT protocols as needed when modifying contrast injection flow rates.
• Exclude patients on ECMO or requiring isolated head CT from high-flow contrast injection protocols until further evidence is available.
• Further research is needed in patient populations with altered cardiac output or specific indications such as pulmonary embolism or CT coronary angiogram.

References

• 1. Factors influencing contrast enhancement in CT imaging
• 2. Risks of high-pressure contrast injection via central venous catheters
• 3. Manufacturer recommendations on standard CVC use for pressure injection
• 4. Development of high-pressure central venous catheters
• 5. Definitions and calculations of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR)